High-throughput cytometry for MSC, iPSC, and CAR-T studies
Learn how you can transform cell therapy screening workflows at all stages of research
22 May 2025
From regenerative medicine to cancer immunotherapy, the promise of cell therapies continues to expand. However, there are many challenges on the path from research to clinical application – particularly amongst analysis. One of the primary frustrations for researchers today is the complexity of advanced cell models, coupled with the need for efficient and scalable workflows that they can use to screen, characterize and monitor therapeutic cells.
This application guide highlights the use of High-Throughput Screening (HTS) by Cytometry to combat these challenges, particularly for mesenchymal stem cell (MSC), induced pluripotent stem cells (iPSC) and CAR-T studies.
Key topics explored:
- Mesenchymal stem cell identity and differentiation
- Optimizing advanced cell models
- Characterization and optimization of iPSCs
- Phenotypic and functional characterization of CAR-T cells
- Characterization of T cell activation
